BILLIE KENNEDY: Open Payments
NPI 1588207658 · MARIETTA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,312 in 71 payments from 14 companies in 2025. Trend: 2023 $1,763 · 2024 $1,415 · 2025 $1,312
Food & beverage: $1,312
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $353 |
| GlaxoSmithKline, LLC. | 16 | $172 |
| Verona Pharma, Inc. | 7 | $164 |
| GENZYME CORPORATION | 7 | $137 |
| Viatris Specialty LLC | 5 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $95 |
| Grifols USA, LLC | 3 | $62 |
| United Therapeutics Corporation | 2 | $43 |
| Insmed, Inc. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
Products named: DUPIXENT, Ohtuvayre, TEZSPIRE, YUPELRI, FASENRA, TRELEGY ELLIPTA, GLASSIA, AIRSUPRA.
Industry payments across OH — which companies pay providers there.
